Bryan Spring

Sponsor: NIH

Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer

The Spring research group, in collaboration with the Enderling lab at Moffit Cancer Center, has been awarded a Physical Sciences Oncology Network grant (NCI U01 CA280849; ~$2.7M) titled “Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer”. The project will harness an integrated experimental—mathematical oncology approach to decipher how to best harness immune sparing and immune stimulation of fractionated photoimmunotherapy to personalize treatments for advanced or recurrent ovarian cancer patients with presently dismal survival rates.